Diabetes doesn’t have a single cause. It’s a group of related conditions that all end in high blood sugar, but the underlying mechanisms are different depending on the type. Type 1 diabetes is driven by immune system destruction of insulin-producing cells. Type 2, which accounts for roughly 90% of cases, results from a combination of insulin resistance and gradual failure of those same cells, with excess fat in the liver and pancreas playing a central role. Gestational diabetes arises from hormonal changes during pregnancy. Understanding these distinct pathways matters because it shapes what can actually be done about each one.
Type 1: The Immune System Attacks
In type 1 diabetes, the body’s own immune cells infiltrate the pancreas and destroy the beta cells responsible for making insulin. Without insulin, glucose builds up in the blood because cells can’t absorb it. This process is autoimmune, meaning the immune system mistakes healthy tissue for a threat. Interestingly, the attack is surprisingly subtle. Fewer than 10% of the insulin-producing cell clusters (called islets) become infiltrated, and it takes as few as 15 immune cells per islet to cause damage. That’s only about twice the number found in a healthy pancreas.
The earliest signs of trouble appear before the disease is formally detected. Blood sugar after meals begins rising months before autoimmune markers even show up in blood tests. One study found a sharp rise in post-meal glucose a full two months before autoantibodies to beta cells were detectable. This suggests that some degree of beta cell stress or death may actually trigger the immune response, not just result from it. Once enough beta cells are destroyed, the body can no longer produce meaningful amounts of insulin, and lifelong insulin replacement becomes necessary.
The exact trigger that sets off this immune attack remains unclear. Genetics play a role, as do environmental factors like viral infections in childhood. But no single cause has been pinpointed, which is why type 1 diabetes can appear in people with no family history of the disease.
Type 2: Fat in the Wrong Places
Type 2 diabetes develops when the body’s cells stop responding properly to insulin, a condition called insulin resistance, and the pancreas eventually can’t compensate by producing more. The root of insulin resistance, in most cases, traces back to fat accumulation in organs that aren’t designed to store it, particularly the liver and pancreas.
When excess calories are consumed over time, fat cells (especially the visceral fat packed around your organs) release free fatty acids into the bloodstream. These fatty acids get taken up by the liver, where they trigger a chain of events that directly blocks insulin signaling. The key culprit appears to be a specific fat molecule called diacylglycerol. When diacylglycerol builds up in liver cells, it activates an enzyme that interferes with the insulin receptor, essentially jamming the lock so insulin can’t turn the key. Research in humans has confirmed that increased diacylglycerol content in the liver, not other fat byproducts, is most strongly associated with liver insulin resistance.
Fat-loaded liver cells also become inflamed. Unprocessed lipids stress the internal machinery of the cell and activate inflammatory pathways that further impair insulin signaling while increasing inflammatory molecule production. This creates a feedback loop: more fat, more inflammation, worse insulin resistance.
The same process occurs in muscle tissue. Free fatty acids impair the ability of muscle cells to absorb glucose from the blood, which is a major problem because skeletal muscle is where the majority of blood sugar is cleared after a meal. Meanwhile, the fat-burdened liver ramps up its own glucose production even when blood sugar is already elevated, because insulin can no longer tell it to stop.
Why the Pancreas Eventually Fails
Insulin resistance alone doesn’t cause diabetes. Plenty of people are insulin resistant for years or decades without developing the disease, because their pancreas compensates by pumping out extra insulin. Type 2 diabetes only develops when beta cells can no longer keep up with demand.
The decline in beta cell function is gradual and often far along by the time of diagnosis. Studies of human pancreatic tissue show that people diagnosed with type 2 diabetes have lost anywhere from 0% to 63% of their beta cell mass, with substantial variation between individuals. This wide range suggests that for some people, the problem is less about cell death and more about the remaining cells not working properly, possibly because fat has accumulated in the pancreas itself and impairs insulin secretion.
This is why type 2 diabetes is progressive. Early on, the pancreas can compensate. The first cracks show up as post-meal blood sugar spikes, when the demand for insulin is highest. Over time, even fasting blood sugar rises as the pancreas falls further behind. By the time a diagnosis is made, the process has typically been underway for years.
The Genetics Behind Risk
Genes don’t cause type 2 diabetes on their own, but they load the dice. The most powerful genetic risk factor identified so far is a gene called TCF7L2. Variations in this gene are estimated to be involved in nearly one-fifth of all type 2 diabetes cases, and it has been consistently replicated across populations with diverse genetic backgrounds. Carrying the highest-risk version of this gene increases your odds of developing diabetes by about 40%.
Other genes affect how the body processes zinc (important for insulin storage), degrades insulin, and develops pancreatic cells. But no single gene is sufficient to cause the disease. Most people who develop type 2 diabetes carry a combination of modest genetic risk factors that, layered on top of excess body fat and inactivity, push the system past a tipping point.
Gestational Diabetes: Hormones Override Insulin
During pregnancy, the placenta releases hormones that naturally increase insulin resistance in the mother. This is actually a feature, not a bug: it ensures that more glucose stays in the bloodstream and reaches the growing fetus. But in some women, this hormone-driven resistance outstrips the pancreas’s ability to compensate.
One mechanism involves leptin, a hormone released by placental cells. Elevated leptin during pregnancy promotes the release of inflammatory molecules (tumor necrosis factor-alpha and interleukin-6) in the placenta, which intensifies insulin resistance beyond the normal range. Women who already have some degree of underlying insulin resistance or genetic susceptibility are at the highest risk. Gestational diabetes typically resolves after delivery when the placenta is gone, but it signals that the metabolic system was already operating near its limits, which is why it significantly raises the risk of developing type 2 diabetes later in life.
The Role of Gut Bacteria
Your gut microbiome influences how your body handles blood sugar in ways researchers are still mapping out. One of the clearest connections involves short-chain fatty acids, particularly butyrate, which are produced by certain bacterial species when they ferment dietary fiber. Butyrate helps regulate the insulin response and tamps down inflammation.
People with type 2 diabetes consistently show lower levels of two key butyrate-producing species: Faecalibacterium prausnitzii and Roseburia intestinalis. In animal studies, supplementing with a butyrate precursor has provided protection against insulin resistance, obesity, and fatty liver. This doesn’t mean gut bacteria are the primary cause of diabetes, but a fiber-poor diet that starves these beneficial species may remove one of the body’s natural buffers against insulin resistance.
Can Type 2 Diabetes Be Reversed?
Because type 2 diabetes is driven largely by fat accumulation in the liver and pancreas, removing that fat can, in some cases, restore normal blood sugar. An international expert consensus defines remission as an HbA1c (a three-month average blood sugar marker) below 6.5% that persists for at least three months without any glucose-lowering medication. This can happen through significant weight loss, dietary changes, or bariatric surgery.
Remission is most achievable early in the disease, before too many beta cells have been lost. The longer someone has had type 2 diabetes, the less likely full remission becomes, because sustained high blood sugar and fat exposure progressively damage the insulin-producing cells. This is one of the strongest arguments for early, aggressive lifestyle intervention: the underlying cause is still reversible in many people if addressed before the pancreas reaches a point of no return.